期刊文献+

组蛋白去乙酰化酶抑制剂对胶质瘤细胞增殖及MKK7表达的影响 被引量:2

Effects for Histone Deacetylase Inhibitors on Proliferation and MKK7 Expression in Glioma Cells
下载PDF
导出
摘要 目的探讨组蛋白去乙酰化酶抑制剂(histone deacetylase inhibitor,HDACI)对胶质瘤细胞增殖及MKK7表达的影响。方法体外培养神经胶质瘤细胞株U251,用脂质体转染MKK7-si RNA1、MKK7-si RNA2和对照si RNA,48 h后Western blot检测MKK7表达及JNK/c-Jun活性,Brd U掺入实验检测细胞增殖情况;用0.5μM组蛋白去乙酰化酶抑制剂曲古菌素A(trichostatin A,TSA)处理细胞8 h,DMSO作对照,Western blot检测MKK7、p-JNK、JNK、p-c-Jun、c-Jun表达或磷酸化水平;用TSA分别处理细胞8、12、24 h,检测各时间点细胞增殖率;用其他组蛋白去乙酰化酶抑制剂包括伏立诺他(suberoylanilide hydroxamic acid,SAHA),丙戊酸(valproic acid,VPA),M344处理细胞检测MKK7表达及细胞增殖。结果同对照组相比,沉默MKK7表达抑制了JNK/c-Jun活性和细胞增殖(P=0.008);TSA处理细胞8 h显著抑制MKK7表达及JNK/c-Jun活性,SAHA、M344、VPA均显著抑制MKK7表达。TSA处理细胞8 h没有抑制细胞增殖,处理12 h显著抑制增殖(P=0.006),24 h抑制效应更明显(P=0.002);SAHA(P=0.001),M344(P=0.008)或VPA(P=0.002)处理细胞12 h均抑制了细胞增殖。结论组蛋白去乙酰化酶抑制剂可通过抑制MKK7表达抑制神经胶质瘤细胞增殖。 Objective To investigate the effects of histone deacetylase inhibitors(HDACIs) on the proliferation and MKK7 expression in glioma cells.Methods Glioma cell line U251 cultured in vitro was transfected with MKK7-si RNA1,MKK7-si RNA2 and control si RNA for 48 h,respectively.Western blot was performed to test MKK7 expression and JNK/c-Jun activities.Brd U incorporation assays were performed to determine the cellular proliferation rate.Cells were treated with 0.5μM HDAC inhibitor Trichostatin A(TSA) for 8h,dimethyl sulfoxide(DMSO) as a control.Western blot was performed to test the expression or phosphorylation levels of MKK7,p-JNK,JNK,p-c-Jun and c-Jun.MTT assays were performed to determine cellular proliferation rate at 8,12,24 h after TSA treatment.Other HDACIs,including suberoylanilide hydroxamic acid(SAHA),valproic acid(VPA) and M344,were used to test if they could inhibit MKK7 expression and cellular proliferation as well.Results Compared with the control group,the knockdown of MKK7 suppressed JNK/c-Jun activities and proliferation rate(P=0.008);HDACI(0.5 μM TSA) treatment for 8h remarkably reduced MKK7 expression and JNK/c-Jun activities,and all other HDACIs(SAHA,M344,VPA) could suppress MKK7 expression as well.TSA treatment for 8 h did not decrease the proliferation rate,while TSA treatment for 12 h signifi cantly inhibited proliferation rate(P=0.006),and treatment for 24 h exhibited more inhibitive effects(P=0.002);SAHA(P=0.001),M344(P=0.008) or VPA(P=0.002) inhibited cellular proliferation as well.Conclusion HDACIs could inhibit MKK7 expression and MKK7-mdiated proliferation in glioma cells.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2016年第1期1-5,共5页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金项目(31171021)
关键词 神经胶质瘤 组蛋白去乙酰化酶抑制剂 MKK7 增殖 Glioma Histone deacetylase inhibitor(HDACI) MKK7 Proliferation
  • 相关文献

参考文献18

  • 1/ Alexandru-Abrams D, Jadus MR, Hsu FP, et al. Therapeuti~ / targeting of malignant glioma[J]. Anticancer Agents Med Chem, 2014, 14(8): 1075-84. /.
  • 2周志龙,步星耀,闫兆月,马春晓,王跃伟,雒建超.脑恶性胶质瘤术后会师化疗同步适形放疗的临床观察[J].肿瘤防治研究,2014,41(4):374-378. 被引量:4
  • 3Kitanaka C, Sato A, Okada M. JNK Signaling in the Control of the Tumor-Initiating Capacity Associated with Cancer Stem Cells[J]. Genes Cancer, 2013, 4(9-10): 388-96.
  • 4Li JY, Wang H, May S, et al. Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas[J]. J Neurooncol, 2008, 88(1): 11-7.
  • 5董林,葛瑞民,祁楠,沈丽.shRNA腺病毒介导的JNK1 RNAi抑制U87MG人胶质瘤细胞的增殖[J].肿瘤防治研究,2011,38(7):767-769. 被引量:2
  • 6Cui J, Han SY, Wang C, et al. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells[J].Cancer Res, 2006, 66(20): 10024-31.
  • 7Bose P, Dai Y, Grant S. Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights[J]. Pharmacol Ther, 2014, 143(3): 323-36.
  • 8Noureen N, Rashid H, Kalsoom S. Identification of type-specific anticancer histone deacetylase inhibitors: road to success[J]. Cancer Chemother Pharmacol, 2010, 66(4): 625-33.
  • 9Slingerland M, Guchelaar HJ, Gelderblom H. Histone deacetylase inhibitors: an overview of the clinical studies in solid tumors[J]. Anticancer Drugs, 2014, 25(2): 140-9.
  • 10Yuan Z, Gong S, Luo J, et al. Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis[J]. Mol Cell Biol, 2009, 29(9): 2431-42.

二级参考文献6

共引文献4

同被引文献17

  • 1Lewis KM, Petritsch C. Asymmetric cell division: implication for glioma dvelopment and treatment. Transl Neurosi, 2013, 4 (4) : 484-503.
  • 2Furnari FB, Fenton T, Baehon RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK. Malignant astrocytic glioma: genet- ics, biology, and paths to treatment. Gene Dev, 2007, 21 (21) : 2683-2710.
  • 3Fischer M, Grossmann P, Padi M, DeCaprio JA. Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks. Nucleic Acids Res, 2016 Jun 8. pii: gkw523. [Epub ahead of print] .
  • 4Johnson J, Thijssen B, McDermott U, Garnett M, Wessels LF, Bernards R. Targeting the RB-E2F pathway in breast cancer. Oncogene, 2016 Feb 29. [ Epub ahead of print] .
  • 5He W, Wu Y, Tang X, Xia Y, He G, Min Z, Li C, Xiong S, Shi Z, Lu Y, Yuan Z. HDAC inhibitors suppress c-Jun/Fra-1- mediated proliferation through transcriptionally downregulating MKK7 and Rafl in neuroblastoma cell. Oncotarget, 2016, 7 (6) : 6727-6747,.
  • 6Udayakumar T, Shareef MM, Diaz DA, Ahmed MM, Pollack A. The E2F1/Rb and p53/MDM2 pathways in DNA repair and ap- optosis : understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy. Semin Radiat Oncol, 2010, 20 (4) : 258-266.
  • 7Meng P, Ghosh R. Transcription addiction: can we garner theYin and Yang functions of E2F1 for cancer therapy? Cell Death Dis, 2014, 5: e1360.
  • 8Llad6 V, L6pez D J, Ibarguren M, Alonso M, Soriano JB, Escribd PV, Busquets X Regulation of the cancer cell membrane lipid composition by NaCHOleate: effects on cell signaling and therapeutical relevance in glioma. Biochim Biophys Acta, 2014, 1838 (6): 1619-1627.
  • 9Xiao B, Tan L, He B, Liu Z, Xn R. MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells. J Transl Me, 2013, 11: 172.
  • 10Yang G, Zhang R, Chen X, Mu Y, Ai J, Shi C, Liu Y, Shi C, Sun L, Rainov NG, Li H, Yang B, Zhao S. MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med, 2011, 89 (10) : 1037-1050.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部